Home > Insider Trading > Filing (0001209191-22-041628)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1812364	Relay Therapeutics Inc.	RLAY	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1709772	A Donald Bergstrom	C/O Relay Therapeutics, Inc. 399 Binney Street, 2Nd Floor Cambridge MA 02139	President, R&D	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-07-06	8,000	$4.12	99,494	No	4	M	Direct
Common Stock	Disposition	2022-07-06	8,000	$20.00	91,494	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2022-07-06	8,000	$0.00	8,000	$4.12

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
170,456		2028-04-09	No	4	M	Direct

Footnotes

The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 7, 2022.
Includes 84,953 shares underlying restricted stock units.
Twenty-five percent (25%) of the shares underlying this option vested on April 2, 2019 and the remainder shall vest in equal quarterly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date.